DHR
ACCUMULATE Danaher Corporation · US
$215.00
—
Prices as of close 2026-07-28
Diagnostics and bioprocessing normalization create a strong earnings rebound setup over the next year.
Future value: $250.00 (+16.28%) · 6-12 months
Buy signals
- ▸Recovery catalysts and institutional sponsorship remain supportive.
Related Health Care picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.